Advances in Natural Products: Basic, Therapeutic, and Computational Approaches in Chronic and Infectious Diseases
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 293
Special Issue Editors
Interests: pharmacognosy; botany; medicinal chemistry; patents in plants; chronic diseases
Interests: medicinal chemistry; cardiovascular diseases; pharmacology; cheminformatics
Interests: natural products; cheminformatics; network pharmacology; fingerprints
Interests: acute myeloid leukemia; cell differentiation; vitamin D and its analogs; retinoids; plant-derived bioactive compounds; redox signaling; calcium signaling; cell cycle regulation; apoptosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Natural products have long been a valuable source of active compounds with diverse structures and a wide range of biological activities. Approximately 50% of current pharmaceuticals are derived directly or indirectly from natural products, primarily from plants. This has created a vibrant research environment focused on potential medical treatments for some of the world’s most pressing diseases, including chronic and infectious illnesses. Given the complex impacts of these diseases on quality of life for the global population, along with the side effects associated with their treatments, there is an urgent need for effective management strategies. The development of natural products is a significant alternative, as modern technology and in silico research have enhanced the discovery, design, and evaluation of more targeted pharmaceutical compounds.
For this Special Issue, we invite submissions focused on basic and computational sciences that explore the pharmaceutical applications of natural products in improving human health in the context of chronic and infectious diseases. We welcome studies on drug extraction, identification, and purification in both preclinical and clinical research. We invite submissions on topics including, but not limited to, cardiovascular diseases, cancers, chronic respiratory and kidney diseases, and infectious diseases caused by microorganisms that affect the global population.
Dr. Maira Huerta-Reyes
Dr. Gil Alfonso Magos-Guerrero
Dr. Oscar Barrera-Vázquez
Prof. Dr. Michael Danilenko
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural products
- chronic diseases
- infectious diseases
- computational
- in silico
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
